Sodium nitrite

FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

Retrieved on: 
torsdag, februari 1, 2024
Hypothermia, Sodium nitrite, Fatigue, Ototoxicity, Cisplatin, Patient, FENC, STS, FDA, Restless, Kidney, TSX, Argyreia nervosa, Communication, Food, Methemoglobinemia, Risk, Dermatitis, Headache, Potassium chloride, Pharmaceutical industry

PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.

Key Points: 
  • PEDMARK is the first and only FDA approved therapy indicated to reduce the risk of ototoxicity (e.g., permanent hearing loss) associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
  • The FDA reminded health care providers that as stated in PEDMARK’s prescribing information , PEDMARK is not substitutable with other sodium thiosulfate products.
  • Sodium nitrite is co-packaged with sodium thiosulfate as a separate vial in some products; it is not present in PEDMARK.
  • The FDA encourages those with any questions to contact [email protected].

$4.24 Billion Food Preservative Market - Global Opportunity Analysis and Industry Forecasts, 2022-2030 - Emerging Markets in Asia-Pacific Region - ResearchAndMarkets.com

Retrieved on: 
tisdag, oktober 18, 2022
Food, Beverage, Retail, IFF, Color, Tate, Kerry, Function, Growth, Population, Ammonia, DuPont, Label, Mark Hix, CAGR, Asthma, Organic acid, SE, Sodium nitrite, Cancer, Plant, Food, Benzoates, Cheese, Application, Environmental impact of meat production, Allergy, EDTA, Food preservation, Associated British Foods, Sodium benzoate, BASF SE, Kemin Industries, USD, International Flavors & Fragrances, BASF, Flavonoid

The "Food Preservative Market by Type, by Function, by Label and by Application - Global Opportunity Analysis and Industry Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Food Preservative Market by Type, by Function, by Label and by Application - Global Opportunity Analysis and Industry Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Also, rising adaption of clean labeled food products that are free of artificial preservatives by food industries owing to increasing health awareness among people along with high demand of organic food products is driving the food preservative market.
  • However, health risk associated with the use of synthetic food preservatives that includes allergy, asthma and cancer is restraining the food preservative market.
  • North America holds the lion share of food preservative market, and is expected to continue its dominance during the forecast period.

Chemtrade Logistics Income Fund Announces $75 Million Bought Deal Equity Offering

Retrieved on: 
måndag, augusti 15, 2022
Securities Act of 1933, Disclosure, Forward-looking statement, GLOBE, Fund, Sale, TSX, RBC Capital Markets, Toronto Stock Exchange, SEC Rule 144A, Zinc oxide, Compliance, NEWS, Asbestos bankruptcy trusts (United States), BMO Capital Markets, COVID-19, NOT, Transport, Intention, News, Offering, Sodium nitrite, FOR, Security (finance), Risk management

TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Chemtrade Logistics Income Fund (“Chemtrade” or the “Fund”) (TSX: CHE.UN) announced today that it has entered into an agreement to sell to a syndicate of underwriters led by BMO Capital Markets and RBC Capital Markets (collectively, the “Underwriters”), on a bought deal basis, 8,700,000 trust units (the “Trust Units”), at a price of $8.65 per Trust Unit (the “Offering Price”) for gross proceeds of approximately $75.3 million (the “Offering”). The Fund has also granted the Underwriters the option to purchase up to $11.3 million of additional Trust Units at the Offering Price to cover over-allotments, exercisable in whole or in part any time up to 30 days following closing of the Offering.

Key Points: 
  • Pending any such use, the net proceeds from the Offering will temporarily be used to reduce indebtedness under the Funds existing credit agreement.
  • Chemtrade believes that additional capacity for ultrapure sulphuric acid is required to support the fast-growing semiconductor industry in the United States.
  • Forward-looking statements in this news release describe the expectations of the Fund and its subsidiaries as of the date hereof.
  • Further information can be found in the disclosure documents filed by the Fund with the securities regulatory authorities, available at www.sedar.com.

Global Processed Meat Market Report (2022 to 2031) - Featuring Cargill, Tyson Foods and Foster Farms Among Others - ResearchAndMarkets.com

Retrieved on: 
torsdag, april 7, 2022
Restaurant, Bar, Food, Beverage, Other Retail, Retail, Supermarket, Benchmark, Risk, Organization, Nuggets, Growth, ITC Limited, Coronavirus, ITC, Meat, Plant, Food, Smoking, Taste, Sodium nitrite, Create, Poultry, Clostridium perfringens, Marketing, Food preservation, Chilled

The processed meat market consists of sales of processed meat by entities (organizations, sole traders, and partnerships) that are preserved by curing, smoking, drying, salting, or canning.

Key Points: 
  • The processed meat market consists of sales of processed meat by entities (organizations, sole traders, and partnerships) that are preserved by curing, smoking, drying, salting, or canning.
  • The different processing's include fresh processed meat, raw cooked meat, precooked meat, raw fermented sausages, cured meat, dried meat, others and involves various meat types such as poultry, beef, mutton, pork, others.
  • The increasing consumption of various processed food products is expected to propel the growth of the processed meat market going forward.
  • The countries covered in the processed meat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Vertellus Completes Acquisition of Specialty Ingredients Businesses from Chemtrade

Retrieved on: 
onsdag, november 3, 2021
Chemicals, Plastics, Manufacturing, United Nations Principles of Medical Ethics, PRI, Vaccine, Hypertension, Zinc oxide, Family, Health, Potassium chloride, Socially responsible investing, TSX, CEO, Sodium nitrite, Diabetes, Acquisition, Globe, Pharmaceutical industry

Vertellus, a manufacturer of specialty products for various consumer goods, food & agriculture, healthcare, and industrial markets, today announced the completion of its acquisition of certain businesses of Chemtrade Logistics Income Fund (TSX: CHE.UN) (Chemtrade) responsible for producing potassium chloride, caustic pellets, and vaccine adjuvants.

Key Points: 
  • Vertellus, a manufacturer of specialty products for various consumer goods, food & agriculture, healthcare, and industrial markets, today announced the completion of its acquisition of certain businesses of Chemtrade Logistics Income Fund (TSX: CHE.UN) (Chemtrade) responsible for producing potassium chloride, caustic pellets, and vaccine adjuvants.
  • This acquisition expands Vertellus capabilities to manufacture and develop specialty ingredients in the dynamic healthcare and pharmaceutical sectors, reach an expanding global base of long-term customers, and strengthen its portfolio in these market segments.
  • John Van Hulle, CEO of Vertellus, said, We are thrilled to welcome these strong Chemtrade businesses to the Vertellus family as we further extend our reach in the high-growth healthcare and pharmaceutical sectors.
  • Headquartered in Indianapolis, The Vertellus group of companies was originally founded in 1857 as a manufacturer of niche specialty products.

Vertellus to Acquire Specialty Chemical Businesses from Chemtrade, Expanding Specialty Ingredients Capabilities in the Healthcare and Pharmaceutical Sectors

Retrieved on: 
torsdag, september 30, 2021
Chemicals, Plastics, Manufacturing, Sodium nitrite, Socially responsible investing, PRI, Vaccine, Health, TSX, Hypertension, Diabetes, CEO, Speciality chemicals, Acquisition, General manager, Growth, Family, United Nations Principles of Medical Ethics, Zinc oxide, Technology, Potassium chloride, VP, Pharmaceutical industry, Fine chemical

This acquisition will expand Vertellus capabilities to manufacture and develop specialty ingredients in high-growth healthcare and pharmaceutical sectors.

Key Points: 
  • This acquisition will expand Vertellus capabilities to manufacture and develop specialty ingredients in high-growth healthcare and pharmaceutical sectors.
  • With this acquisition, Vertellus will reach an expanding global base of long-term customers and strengthen its portfolio in these dynamic market segments.
  • John Van Hulle, CEO of Vertellus, said, We are pleased to welcome these strong businesses and talented teams to the Vertellus family.
  • The addition of these growth-oriented businesses to Vertellus will strengthen our commitment to our customers and help us meet increasing demand for these critical healthcare and pharmaceutical specialty ingredients.

JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets

Retrieved on: 
tisdag, juli 21, 2020
Chemical substances, Garde manger, Preservatives, Chemistry, Materials, Nitrogen cycle, Antidotes, Sodium compounds, Nitrite, Sodium nitrite, Diabetic neuropathy, Peripheral neuropathy

The sodium nitrite sustained release tablet is the clinical candidate TV1001SR, formulated to treat PAD and other vascular conditions.

Key Points: 
  • The sodium nitrite sustained release tablet is the clinical candidate TV1001SR, formulated to treat PAD and other vascular conditions.
  • Sodium nitrite has demonstrated positive results on vascular conditions, such as PAD, diabetic neuropathy and even vascular decline associated with normal aging.
  • In previous preclinical and clinical studies, sodium nitrite has shown promise repairing and restoring vascular function with minimal adverse events.
  • In addition, in an aged mice study, nitrite administration has been shown to reduce the production of vascular inflammation and thrombosis (blockages).

Global Sodium Nitrite (CAS 7632-00-0) Market Report 2019: Applications, Manufacturing Methods, Patents, Prices & End-Use Sectors

Retrieved on: 
fredag, februari 22, 2019
Chemical substances, Chemistry, Physical sciences, Preservatives, Garde manger, Oxidizing agents, Antidotes, Nitrites, Sodium nitrite, Sodium

The "Sodium Nitrite (CAS 7632-00-0) Market Research Report 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sodium Nitrite (CAS 7632-00-0) Market Research Report 2019" report has been added to ResearchAndMarkets.com's offering.
  • This Global Report 2019 is a result of industry experts' diligent work on Researching the world market of sodium nitrite.
  • The forth chapter deals with sodium nitrite market trends review, distinguish sodium nitrite manufacturers and suppliers.
  • The sodium nitrite global market Report 2019 key points: